Best Momentum Stocks to Buy for February 23rd

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 23:

Constellium SE CSTM: This aluminum manufacturing company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.6% over the last 60 days.

Constellium SE Price and Consensus

Constellium SE price-consensus-chart | Constellium SE Quote

Constellium's shares gained 63.7% over the last three months compared with the S&P 500’s decline of 3.7%. The company possesses a Momentum Score of A.

Constellium SE Price

Constellium SE price | Constellium SE Quote

Nova Ltd. NVMI: This semiconductor equipment company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.

Nova Ltd. Price and Consensus

Nova Ltd. price-consensus-chart | Nova Ltd. Quote

Nova's shares gained 48.0% over the last three months compared with the S&P 500’s decline of 3.7%. The company possesses a Momentum Score of A.

Nova Ltd. Price

Nova Ltd. price | Nova Ltd. Quote

Nicolet Bankshares, Inc. NIC: This bank holding company for Nicolet National Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.3% over the last 60 days.

Nicolet Bankshares Inc. Price and Consensus

Nicolet Bankshares Inc. price-consensus-chart | Nicolet Bankshares Inc. Quote

Nicolet Bankshares' shares gained 31.9% over the last three months compared with the S&P 500’s decline of 3.7%. The company possesses a Momentum Score of A.

Nicolet Bankshares Inc. Price

Nicolet Bankshares Inc. price | Nicolet Bankshares Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research